• 1. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 2. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 5. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Steroids and steroid derivatives Gluco/mineralocorticoids, progestogins and derivatives
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Steroids and steroid derivatives Pregnane steroids Gluco/mineralocorticoids, progestogins and derivatives

Introduction to 20-Dihydroprogesterone Acetate (CAS No: 5062-62-4)

20-Dihydroprogesterone Acetate, with the chemical formula CAS No: 5062-62-4, is a significant compound in the field of pharmaceutical chemistry and biochemistry. This compound, also known as pregnenolone acetate, is a derivative of progesterone and has garnered considerable attention due to its diverse biological activities and potential therapeutic applications. As a progestogen, it plays a crucial role in hormonal regulation and has been extensively studied for its effects on the reproductive system, metabolism, and inflammation.

The synthesis and characterization of 20-Dihydroprogesterone Acetate have been subjects of intense research, particularly in the development of novel drug formulations. The compound’s structural modification allows for fine-tuning of its pharmacokinetic properties, making it a valuable intermediate in the synthesis of more complex steroid derivatives. Recent advancements in synthetic methodologies have enabled the production of high-purity 20-Dihydroprogesterone Acetate, facilitating its use in both preclinical and clinical studies.

In recent years, 20-Dihydroprogesterone Acetate has been explored for its potential role in managing various medical conditions. One of the most promising areas of research is its application in reproductive health. Studies have indicated that this compound may help regulate menstrual cycles and alleviate symptoms associated with hormonal imbalances. Additionally, its anti-inflammatory properties have been investigated, suggesting potential benefits in conditions such as endometriosis and polycystic ovary syndrome (PCOS).

The pharmacological profile of 20-Dihydroprogesterone Acetate has been further elucidated through numerous in vitro and in vivo studies. These investigations have highlighted its ability to modulate steroid receptor activity, which is critical for developing targeted therapies. For instance, research has demonstrated that 20-Dihydroprogesterone Acetate can interact with the progesterone receptor (PR) and estrogen receptor (ER), leading to differential signaling pathways that could be exploited for therapeutic gain.

Moreover, the compound’s metabolic stability has been a focal point of interest. The acetate ester form enhances solubility and bioavailability, making it an attractive candidate for oral administration. This characteristic is particularly advantageous in drug development, as it allows for easier formulation and patient compliance. Current research is also exploring the use of 20-Dihydroprogesterone Acetate in combination therapies, where it may synergize with other compounds to improve treatment outcomes.

The role of 20-Dihydroprogesterone Acetate in neuroprotection has emerged as a novel area of investigation. Preliminary studies suggest that this compound may have neurosteroid-like effects, potentially benefiting conditions such as Alzheimer’s disease and stroke. The ability of 20-Dihydroprogesterone Acetate to cross the blood-brain barrier and exert protective effects on neural cells makes it a promising candidate for further exploration.

In conclusion, 20-Dihydroprogesterone Acetate (CAS No: 5062-62-4) represents a versatile and multifaceted compound with significant implications in pharmaceutical research. Its diverse biological activities, coupled with advancements in synthetic chemistry and drug delivery systems, position it as a valuable asset in the development of new therapeutic agents. As ongoing research continues to uncover its potential applications, 20-Dihydroprogesterone Acetate is poised to play an increasingly important role in modern medicine.

• 83646-86-0(3beta-Acetoxy-6-ethyl-1,2,3,3a,4,5,8,9,9a,9b-decahydro-3abeta-methyl-7H-benz[e]inden-7-one)
• 119020-36-9([6,6'-Biestr-4-ene]-3,3'-dione,17,17'-bis(acetyloxy)-7,7'-di-2-propenyl-, (6b,7a,17b)-(6'b,7'a,17'b)-)
• 37717-06-9([(3S,5S,6S,8S,10S,13S,14S,17R)-6-Acetyloxy-10,13-dimethyl-17-[(Z)-6-methyl-4-oxohept-2-en-2-yl]-2,3,4,5,6,7,8,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate)
• 434-05-9(Metenolone acetate)
• 1045-69-8(Testosterone acetate)
• 14610-49-2(Androst-4-en-3-one,17-(acetyloxy)-7-methyl-, (7b,17b)- (9CI))
• 85761-68-8(Gon-4-en-3-one,1,17-bis(acetyloxy)-13-ethyl-, (1b,17b)- (9CI))
• 1242-56-4(Androst-1-en-3-one,17-(acetyloxy)-2-methyl-, (5a,17b)-)
• 1425-10-1(Nandrolone acetate)
• 104508-86-3(Cholest-4-en-3-one, 7-(acetyloxy)-, (7a)-)